See the DrugPatentWatch profile for cosentyx

Cosentyx is a biologic medication used to treat psoriatic arthritis (PsA) and other conditions. For PsA, Cosentyx is administered through subcutaneous injections every 2 weeks.

According to the prescribing information provided by Novartis, the manufacturer of Cosentyx, the recommended dosage for PsA is 150 mg every 2 weeks [1]. This dosage has been shown to be effective in reducing the signs and symptoms of PsA, including joint pain and swelling.

It's worth noting that the frequency of injections may vary depending on the individual patient's response to treatment. In some cases, the dosage may need to be adjusted or the injection frequency may need to be changed [2].

It's also important to note that Cosentyx is a self-administered medication, and patients are typically trained on how to inject themselves by a healthcare provider or pharmacist [3]. This allows patients to receive treatment in the comfort of their own homes, which can be beneficial for those with mobility issues or those who live in remote areas.

In terms of cost, the price of Cosentyx varies depending on the country and region. According to DrugPatentWatch.com, the average wholesale price of Cosentyx in the United States is around $1,400 per 150 mg injection [4].

Sources:

[1] Novartis. (2022). Cosentyx Prescribing Information.

[2] National Psoriasis Foundation. (n.d.). Cosentyx.

[3] American Academy of Dermatology. (n.d.). Psoriatic Arthritis: Treatment.

[4] DrugPatentWatch.com. (n.d.). Cosentyx (Secukinumab) Prices.